1. Angel Robotics H1 2025 Performance: A Mixed Bag

Angel Robotics reported KRW 1.4 billion in revenue, an operating loss of KRW 2.1 billion, and a net loss of KRW 1.9 billion for the first half of 2025. Underperformance in the ‘angel MEDI’ segment and increased R&D spending contributed to the negative results. However, the ‘angel SUIT’ segment showed promise with a robust growth rate of 104.06%.

2. Analyzing the Downturn: ‘angel MEDI’ Struggles and R&D Investment

Sales in the ‘angel MEDI’ segment declined by 63.01% year-over-year. Meanwhile, R&D expenditure reached KRW 960.9 million, representing 37.5% of revenue, highlighting the company’s commitment to future growth.

3. Future Growth Drivers: ‘angel SUIT’ Success and Global Expansion

The impressive growth of the ‘angel SUIT’ segment, coupled with expansion into Southeast Asian markets like Thailand and Vietnam, and plans for entry into Europe and the US, fuel optimism for future growth. Additionally, the development of the ‘Angel’a’ digital healthcare platform is poised to expand the company’s business model.

4. Investor Action Plan: Cautious Observation and Key Watch Points

While Angel Robotics holds significant potential, the current financial performance warrants a cautious investment approach. Investors should monitor key factors such as the sustained growth of ‘angel SUIT,’ improvement in ‘angel MEDI’ performance, success in overseas markets, R&D investment efficiency, and future earnings announcements.